LG Chem Ltd (XKRX:051910)
â‚© 267,000 -1,000 (-0.37%) Market Cap: 19.79 Tn Enterprise Value: 60.86 Tn PE Ratio: 0 PB Ratio: 0.59 GF Score: 85/100

Q2 2026 LG Chem Ltd Earnings Call Transcript

Jul 31, 2026 / 05:00AM GMT
Release Date Price: â‚©258000 (+5.09%)

Key Points

Positve
  • LG Chem Ltd (XKRX:051910) achieved a consolidated operating margin of 4.2% in Q2 2026, with profitability improving across Petrochemicals, Advanced Materials, and LG Energy Solution.
  • The Petrochemical division saw a significant earnings improvement in Q2, driven by positive inventory lagging effects, wider spreads, and one-off factors such as US reciprocal tariff refunds.
  • Advanced Materials returned to profitability in Q2, supported by higher cathode material selling prices, expanded separator shipments, and the ramp-up of mass production for new electronic materials products.
  • LG Energy Solution returned to profitability in Q2, driven by higher shipments of batteries for ESS applications and lower fixed cost burden from increased North American ESS production.
  • The company is making strategic progress in high-value-added products, including EV-grade SSBR, semiconductor-grade IPA, and ultra-high molecular weight PVC, with sales expected to grow over 40% YoY and contribute to a more profitable portfolio by 2030.
  • LG Chem Ltd (XKRX:051910) is advancing its future growth businesses, including electronic materials (SGF film, CCL for non-memory semiconductors) and AI-based drug discovery, with new customer wins and partnerships like LabGenius.
Negative
  • LG Chem Ltd (XKRX:051910) expects Q3 2026 profitability to come under pressure in Petrochemicals due to negative inventory lagging effects from declining feedstock prices and higher logistics costs (shipping costs up 60% H2 vs H1).
  • The cathode business faces slower-than-expected recovery in North American EV demand, making it challenging to meet initial 2026 volume targets, with growth limited by the suspension of Ultium sales production and customer adjustments.
  • Life Sciences profitability is expected to decline QoQ in Q3 due to export shipments of certain products (including vaccines) being concentrated in Q4 and increased R&D expenses for key clinical developments.
  • The Petrochemical business faces significant market uncertainty from the Middle East conflict, with volatile raw material costs and a wait-and-see approach from customers, leading to product prices not keeping pace with material costs.
  • The business restructuring with the refining partner is complex and requires multiple approvals (domestic and international), which may take time to execute post-approval, delaying the full benefits of the transformation.
  • The company's net profit in Q2 was only KRW67 billion, significantly lower than operating profit (KRW600 billion), indicating high non-operating costs or losses that weigh on the bottom line.
Gyeong;Seok Gim
LG Chem Ltd - Head of Investor Relations

Good afternoon. We'll now start LG Chem's 2026 second-quarter earnings conference call. This is Gyeong-Seok Gim, Head of IR at LG Chem.

Thank you for taking an interest in LG Chem and taking the time to join us today amidst your busy schedules. We will begin with a brief overview of the 2026 Q2 earnings performance. Then our CFO will present the highlights of this earnings announcement, after which we will move on to the Q&A session.

Please note that the presentations will be interpreted simultaneously, while the Q&A session will be interpreted consecutively. For those with web access, the materials presented during this conference call can be viewed online and are also available for download from our corporate website.

Let's begin today's call with the introduction of the management team. We have CFO, Dong Seok Cha; Cheol-Ho Yang, Head of Business Strategy from Petrochemical Division; Young Seok Lee, Head of Business Strategy for Advanced Materials Division; and Dal-Mi Hwang, Head of Business

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot